Health Care·Pharmaceuticals·$3.3B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.87 | N/A | N/A |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $-0.87 | N/A | N/A |
| Revenue | N/A | N/A | N/A |
Tone: Defensive
Management expressed caution regarding current market conditions. They emphasized a commitment to long-term growth despite recent challenges.
Management did not provide specific revenue figures for the quarter.
The company is focused on strategic initiatives moving forward.
Liquidia Corp's first quarter results showed a significant loss per share, which contributed to an 8.57% decline in stock price. The lack of revenue data and guidance may raise concerns among investors about the company's future performance. Management's cautious tone suggests they are navigating challenges but remain focused on long-term strategies.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
WESTERN DIGITAL CORP
Apr 29, 2019